Habib Nargues S, Mahran Mona A
Pharmaceutical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt.
Boll Chim Farm. 2004 Oct;143(8):299-307.
Four novel series of 1,4-naphthoquinone derivatives namely 2,3-disubstiuted 4-[(benzothiazol-2-yl)hydrazono]-1,4-dihydronaphthalen-1-one 4a-c, N1-(2,3-disubstituted-4-oxo-1,4-dihydronaphthalen-1-ylidene)-N2-(benzotriazol-1-yl)acetic acid hydrazide 5a-c, 2,3-disubstituted 4-[(5-aryl-2,3-dihyrothiazol-2-ylidene)hydrazono]-1,4-dihydronaphthalen-1-one 7a-c, and 3-methyl-2-substituted carbamoyl or thiocarbamoyl-hydrazinocarbonylmethylthio-1,4-dihydronaphthalene-1,4-dione 9a-c were synthesized. Three of the new compounds were chosen by NCI to be evaluated as anticancer agents and they showed promising activity. All the prepared compounds were tested as antimicrobial agents.
合成了四个新型的1,4-萘醌衍生物系列,即2,3-二取代的4-[(苯并噻唑-2-基)腙]-1,4-二氢萘-1-酮4a - c、N1-(2,3-二取代-4-氧代-1,4-二氢萘-1-亚基)-N2-(苯并三唑-1-基)乙酰肼5a - c、2,3-二取代的4-[(5-芳基-2,3-二氢噻唑-2-亚基)腙]-1,4-二氢萘-1-酮7a - c以及3-甲基-2-取代氨基甲酰基或硫代氨基甲酰基-肼基羰基甲基硫代-1,4-二氢萘-1,4-二酮9a - c。美国国立癌症研究所选择了其中三种新化合物作为抗癌剂进行评估,它们显示出有前景的活性。所有制备的化合物都作为抗菌剂进行了测试。